Stats from the Veterinary Industry Tracker powered by Vetsource and AVMA
June 23–29, 2024
Last week, Elanco announced updates regarding expected FDA approval timelines for two new products: Zenrelia and Credelio Quattro.
According to Elanco, the FDA confirmed that all three major technical sections — Chemistry, Manufacturing, and Controls (CMC), as well as Effectiveness and Safety — are complete for Zenrelia, a JAK inhibitor intended to control pruritus and atopic dermatitis in dogs. FDA approval of the product is expected late in the third quarter of this year, and Elanco foresees a fourth-quarter U.S. launch.
A Zenrelia trial on unvaccinated dogs dosed at three times the label dose led to Elanco’s expectation that a safety warning would be required for Zenrelia labels in the U.S.
Elanco’s Credelio Quattro, a broad-spectrum oral parasiticide protecting against fleas, ticks, and internal parasites, has passed the FDA’s Effectiveness and Safety sections. The company expects FDA approval during the fourth quarter of 2024, and a U.S. launch in early 2025.
For complete details, read Elanco’s press release here. [1]
Check out the Veterinary Industry Tracker [2] for daily stats.
| -0.5% Revenue YoY (Last Week) |
-7.2% Visits YoY (Last Week) |
Veterinary industry year-over-year revenue was flat last week at -0.5%, falling into negative territory for the first time since January. Year-over-year visits continued to decline, falling to -7.2%, a nearly 5% drop from the previous week’s -2.3%.
 -10.8%Heartworm YoY |
-11.6% Flea/Tick YoY |
 +1.7%Services YoY |
-6.7% Products YoY |
Year-over-year parasiticide protection plummeted last week, with heartworm protection at -10.8% and flea/tick protection at -11.6%, drops from the prior week’s -7.6% and -5.9% respectively. Year-over-year services revenue was 1.7%, a decline from 4.3% the previous week, and product revenue was -6.7%, compared to -2.0% the week prior.
| +4.7% Revenue YoY (Last 12 Months) |
-2.1% Visits YoY (Last 12 Months) |
The rolling 14-day trendline shows revenue and visits declining since mid-June.
| 5,564 Practices |
2.1M Revenue per Practice (Last 12 Months) |
10.5K Visits per Practice (Last 12 Months) |
New Mexico topped every other state last week in year-over-year revenue and visits at 10.7% and 0.1% respectively. New Hampshire came in second for revenue at 7.7%, while year-over-year visits for Minnesota and North Carolina trailed closely behind New Mexico’s visits at 0.0%.
*Numbers are subject to change based on data availability and PIMS adjustments.
Need additional stats? You got it.
The Premium Veterinary Industry Tracker lets you drill into revenue categories, visit types, date ranges, states, and more.
| LEARN MORE » [3] |